Cargando…

Taxanes in the Treatment of Advanced Gastric Cancer

Although rapid advances in treatment options have improved the prognosis of advanced gastric cancer (AGC), it remains a major public health problem and the second leading cause of cancer-related deaths in the world. Taxanes (paclitaxel and docetaxel) are microtubule stabilizing agents that inhibit t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Byung Woog, Kwon, Oh-Kyoung, Chung, Ho Young, Yu, Wansik, Kim, Jong Gwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274234/ https://www.ncbi.nlm.nih.gov/pubmed/27196887 http://dx.doi.org/10.3390/molecules21050651

Ejemplares similares

Clinical Significance of MET Gene Copy Number in Patients with Curatively Resected Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2015)

Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer
por: Baek, Dong Won, et al.
Publicado: (2017)

Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer
por: Seo, An Na, et al.
Publicado: (2017)

Early Postoperative Intraperitoneal Chemotherapy for Macroscopically Serosa-Invading Gastric Cancer Patients
por: Kwon, Oh Kyoung, et al.
Publicado: (2014)

High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2017)

Improved Survival of a Patient with Gastric and Other Multiple Metastases from Ovarian Cancer by Multimodal Treatment: A Case Report
por: Hwangbo, Seonmi, et al.
Publicado: (2015)

Clinical significance of insulin-like growth factor gene polymorphisms with survival in patients with gastrointestinal stromal tumors
por: Kwon, Ohkyoung, et al.
Publicado: (2012)

Clinical Impact of Prognostic Nutrition Index for Advanced Gastric Cancer Patients with Peritoneal Metastases Treated Nivolumab Monotherapy
por: Lee, Jungmin, et al.
Publicado: (2022)

Chronological Changes in Quality of Life after Distal Gastrectomy for Gastric Cancer
por: Park, Ki Bum, et al.
Publicado: (2017)

Chronological Changes of Quality of Life in Long-Term Survivors after Gastrectomy for Gastric Cancer
por: Yu, Wansik, et al.
Publicado: (2016)

Endoscopic and Laparoscopic Full-Thickness Resection of Endophytic Gastric Submucosal Tumors Very Close to the Esophagogastric Junction
por: Kwon, Oh Kyoung, et al.
Publicado: (2015)

Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology
por: Kang, Byung Woog, et al.
Publicado: (2017)

Impact of Body Mass Index on the Quality of Life after Total Gastrectomy for Gastric Cancer
por: Park, Ki Bum, et al.
Publicado: (2018)

Midterm body composition changes after open distal gastrectomy for early gastric cancer
por: Park, Ki Bum, et al.
Publicado: (2018)

Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
por: Kim, Jin Won, et al.
Publicado: (2019)

Preoperative Quality of Life in Patients with Gastric Cancer
por: Suk, Hyoam, et al.
Publicado: (2015)

Biweekly Irinotecan and Cisplatin as Second-line Chemotherapy in Pretreated Patients with Advanced Gastric Cancer: A Multicenter Phase II Study
por: Baek, Jin Ho, et al.
Publicado: (2005)

Changes of Quality of Life after Gastric Cancer Surgery
por: Kong, Horyon, et al.
Publicado: (2012)

Impact of body mass index on quality of life after distal gastrectomy for gastric cancer
por: Park, Ki Bum, et al.
Publicado: (2019)

Using Quality of Life Scales with Nutritional Relevance after Gastrectomy: a Challenge for Providing Personalized Treatment
por: Lee, Seung Soo, et al.
Publicado: (2017)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
por: Kianersi, Shirin, et al.
Publicado: (2023)

Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter study
por: Kwon, Oh Kyoung, et al.
Publicado: (2016)

Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
por: Park, Ji Soo, et al.
Publicado: (2011)

Molecular target: pan-AKT in gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2020)

The Predictive Value of Epstein-Barr Virus-Positivity in Patients Undergoing Gastrectomy Followed by Adjuvant Chemotherapy
por: Baek, Dong Won, et al.
Publicado: (2018)

Molecular targeted therapy for advanced gastric cancer
por: Kim, Jong Gwang
Publicado: (2013)

Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma
por: Choi, Su Jin, et al.
Publicado: (2019)

Predictive Factors for Lymph Node Metastasis in Signet Ring Cell Gastric Cancer and the Feasibility of Endoscopic Submucosal Dissection
por: Kim, Ji Yeon, et al.
Publicado: (2013)

Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2020)

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer
por: Imai, Hiroo, et al.
Publicado: (2018)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Taxanes for the Treatment of Metastatic Breast Cancer
por: Gradishar, W.J.
Publicado: (2012)

Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer
por: Bae, Bong Kyung, et al.
Publicado: (2017)

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer
por: Kim, S T, et al.
Publicado: (2005)

Chronological changes in quality of life and body composition after gastrectomy for locally advanced gastric cancer
por: Park, Ki Bum, et al.
Publicado: (2020)

Quercetin Synergistically Inhibit EBV-Associated Gastric Carcinoma with Ganoderma lucidum Extracts
por: Huh, Sora, et al.
Publicado: (2019)

Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
por: Satake, Hironaga, et al.
Publicado: (2018)

Efficacy and safety of taxane-based systemic chemotherapy of advanced gastric cancer: A systematic review and meta-analysis
por: Shi, Jinxin, et al.
Publicado: (2017)

The taxanes: toxicity and quality of life considerations in advanced ovarian cancer
por: Guastalla III, J P, et al.
Publicado: (2003)

Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3mjbsubhenovj1gs8r04pqpa4f